Insulet
PODD
#2012
Rank
NZ$17.57 B
Marketcap
NZ$253.67
Share price
-0.30%
Change (1 day)
-50.20%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Market capitalization of Insulet (PODD)

Market cap: NZ$17.57 Billion

As of June 2026 Insulet has a market cap of NZ$17.57 Billion. This makes Insulet the world's 2012th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insulet from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$17.57 B-49.92%
2025NZ$35.08 B6.39%
2024NZ$32.97 B37.63%
2023NZ$23.95 B-25.6%
2022NZ$32.20 B19.86%
2021NZ$26.86 B15.02%
2020NZ$23.35 B46.58%
2019NZ$15.93 B127.67%
2018NZ$6.99 B23.81%
2017NZ$5.65 B80.97%
2016NZ$3.12 B-0.72%
2015NZ$3.14 B-4.93%
2014NZ$3.30 B33.6%
2013NZ$2.47 B98.59%
2012NZ$1.24 B9.09%
2011NZ$1.14 B25.25%
2010NZ$0.91 B22.99%
2009NZ$0.74 B117.68%
2008NZ$0.34 B-56.6%
2007NZ$0.78 B

End of Day market cap according to different sources

On Jun 16th, 2026 the market cap of Insulet was reported to be:

NZ$17.57 Billion
by Nasdaq info icon info icon
NZ$17.57 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$972.38 B 5,434.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$271.11 B 1,442.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$179.32 B 920.61%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$1.719 T 9,685.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ$1.96 B-88.82%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$6.11 B-65.21%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$48.48 B 175.97%๐Ÿ‡บ๐Ÿ‡ธ USA